19092-Solid Tumors-NA-596

Solid Tumors

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number:

  • Address

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

Search by practice name, trial titles, indicators and specific disease types.